Concept information
Terme préférentiel
lipopeptide
Concepts spécifiques
- Ac-Asp-N(6)-[(2,2,2-trifluoroethoxy)acetyl]-KATIGFEVQEE
- Ac-Asp-N(6)-[2,5-bis(trifluoromethyl)benzoyl]-KATIGFEVQEE
- Ac-Asp-N(6)-{(2E)-3-[2-(trifluoromethyl)phenyl]prop-2-enoyl}-KATIGFEVQEE
- Ac-Asp-N(6)-[(2E)-3-(3-nitrophenyl)prop-2-enoyl]-KATIGFEVQEE
- Ac-Asp-N(6)-{(2E)-3-[3-(trifluoromethyl)phenyl]prop-2-enoyl}-KATIGFEVQEE
- Ac-Asp-N(6)-[(2E)-3-(4-chlorophenyl)prop-2-enoyl]-KATIGFEVQEE
- Ac-Asp-N(6)-{(2E)-3-[4-(trifluoromethyl)phenyl]prop-2-enoyl}-KATIGFEVQEE
- Ac-Asp-N(6)-[(2E)-3-(m-tolyl)prop-2-enoyl]-KATIGFEVQEE
- Ac-Asp-N(6)-[(2-iodophenyl)carbonyl]-KATIGFEVQEE
- Ac-Asp-N(6)-[2-(trifluoromethyl)benzoyl]-KATIGFEVQEE
- Ac-Asp-N(6)-{3-[2-(trifluoromethyl)phenyl]propanoyl}-KATIGFEVQEE
- Ac-Asp-N(6)-[3-(trifluoromethyl)benzoyl]-KATIGFEVQEE
- Ac-Asp-N(6)-(4-bromobenzoyl)-KATIGFEVQEE
- Ac-Asp-N(6)-[4-(trifluoromethyl)benzoyl]-KATIGFEVQEE
- Ac-Asp-N(6)-(5-chloropentanoyl)-KATIGFEVQEE
- Ac-Asp-N(6)-(6-bromohexanoyl)-KATIGFEVQEE
- Ac-Asp-N(6)-(chloroacetyl)-KATIGFEVQEE
- Ac-Asp-N(6)-(octanoyl)-KATIGFEVQEE
- aculeacin A
- ciliatamide A
- ciliatamide B
- daptomycin
- diacyl lipopeptide
- dragomabin
- dragonamide A
- echinocandin
- emericellamide
- glycopeptidolipid
- lipopeptide antibiotic
- liraglutide
- malacidin A
- malacidin B
- N-Ac-Asp-N(6)-lipoyl-KATIGFEVQEE
- N-tetradecanoylglycylpeptide
- Para-LP-01
- polymyxin
- semaglutide
- syringomycin
- triacyl lipopeptide
Appartient au groupe
URI
http://data.loterre.fr/ark:/67375/KFP-C7RGBQX5-X
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}